noom glp 1 reddit GLP-1 Access and Transparency Noom expands its GLP-1 range
Description
Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes 2020
Always sit upright for some time after eating food to avoid side effects such as acid reflux and vomiting
Although price has reemerged as a key barrier this year as it did in 2024, with 41% of users stopping in 2026 because its too expensive
Blue Cross Blue Shield cited high costs and a surge in spending on GLP-1 drugs
The risk is real but small in absolute terms
